Gulyas Z, Horvath Z, Hajtman L, Kovacs A, Kohut L, Kosa I
Front Cardiovasc Med. 2024; 11:1338066.
PMID: 38450368
PMC: 10914969.
DOI: 10.3389/fcvm.2024.1338066.
Ketema E, Ahsan M, Zhang L, Karwi Q, Lopaschuk G
Sci Rep. 2024; 14(1):1193.
PMID: 38216627
PMC: 10786925.
DOI: 10.1038/s41598-024-51571-0.
Ding X, Wu S, Chen H, Zhao X, Li H
BMC Cardiovasc Disord. 2019; 19(1):163.
PMID: 31272376
PMC: 6610988.
DOI: 10.1186/s12872-019-1140-1.
Xie Z, Lorkiewicz P, Riggs D, Bhatnagar A, Srivastava S
J Chromatogr B Analyt Technol Biomed Life Sci. 2018; 1099:83-91.
PMID: 30248561
PMC: 6398444.
DOI: 10.1016/j.jchromb.2018.09.012.
Shah B, Amoroso N, Sedlis S
Am J Med Sci. 2011; 343(4):321-6.
PMID: 21946827
PMC: 6832689.
DOI: 10.1097/MAJ.0b013e31822fb423.
Hypothalamo-pituitary-adrenal axis in acute myocardial infarction treated by percutaneous transluminal coronary angioplasty: effect of time of presentation.
Paganelli F, Frachebois C, Velut J, Boullu S, Sauze N, Rosso J
J Endocrinol Invest. 2003; 26(5):407-13.
PMID: 12906367
DOI: 10.1007/BF03345195.
Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective.
Wolff A, Rotmensch H, Stanley W, Ferrari R
Heart Fail Rev. 2002; 7(2):187-203.
PMID: 11988642
DOI: 10.1023/a:1015384710373.
Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction.
Christensen N, Videbaek J
J Clin Invest. 1974; 54(2):278-86.
PMID: 4847245
PMC: 301555.
DOI: 10.1172/JCI107763.
Objective haemodynamic assessment after acute myocardial infarction.
Scheidt S, WILNER G, Fillmore S, Shapiro M, Killip T
Br Heart J. 1973; 35(9):908-16.
PMID: 4741919
PMC: 458728.
DOI: 10.1136/hrt.35.9.908.
Prognostic index for myocardial infarction treated in a coronary care unit.
Chapman B, GRAY C
Br Heart J. 1973; 35(2):135-41.
PMID: 4690535
PMC: 458580.
DOI: 10.1136/hrt.35.2.135.
[Experimental myocardial infarction (author's transl)].
Tschirkov V
Basic Res Cardiol. 1974; 69(2):113-60.
PMID: 4546565
DOI: 10.1007/BF01906198.
Acute determination of plasma glycerol as a means of predicting arrhythmias in patients with myocardial ischaemia.
Carlstrom S, Gustafson A
Br Heart J. 1974; 36(10):996-1000.
PMID: 4433455
PMC: 1020049.
DOI: 10.1136/hrt.36.10.996.
Neuroendocrine activation after acute myocardial infarction.
McAlpine H, Morton J, Leckie B, Rumley A, Gillen G, Dargie H
Br Heart J. 1988; 60(2):117-24.
PMID: 3415870
PMC: 1216532.
DOI: 10.1136/hrt.60.2.117.
Effects of free fatty acids on electrophysiological properties of ventricular myocardium.
Luderitz B, Naumann dAlnocourt C, Steinbeck G
Klin Wochenschr. 1976; 54(7):309-13.
PMID: 1263406
DOI: 10.1007/BF01471576.
Urinary catecholamine excretion and thyroid hormone blood level in the course of severe acute brain damage.
Haider W, BENZER H, Krystof G, Lackner F, MAYRHOFER O, STEINBEREITHNER K
Eur J Intensive Care Med. 1975; 1(3):115-23.
PMID: 812705
DOI: 10.1007/BF00571658.
Plasma adrenaline and noradrenaline concentrations and dopamine-beta-hydroxylase activity in myocardial infarction with and without cardiogenic shock.
Benedict C, Grahame-Smith D
Br Heart J. 1979; 42(2):214-20.
PMID: 486283
PMC: 482137.
DOI: 10.1136/hrt.42.2.214.
Catecholamines and diabetes mellitus.
Christensen N
Diabetologia. 1979; 16(4):211-24.
PMID: 372039
DOI: 10.1007/BF01221946.
